Advanced in Neonatal Onset Multisystem Inflammatory Disease

Tomoyuki Imagawa

Yokohama, JP 
Advanced in Neonatal Onset Multisystem Inflammatory Disease
Yokohama, JP 
OverviewLocationsClinical Research

Overview

Tomoyuki Imagawa practices in Yokohama, Japan. Mr. Imagawa is rated as an Advanced expert by MediFind in the treatment of Neonatal Onset Multisystem Inflammatory Disease. His top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Arthritis, Familial Cold Autoinflammatory Syndrome, Neonatal Onset Multisystem Inflammatory Disease, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Neonatal Onset Multisystem Inflammatory Disease.

Gender
Male

Locations

Yokohama, Japan
Other Locations
Kanagawa, Japan
Shimotsuke, Japan
Tokyo, Japan
Kagoshima, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3

61 Total Publications

Toxic Shock Syndrome Caused by Streptococcus dysgalactiae Subspecies equisimilis: A Report of a Rare Pediatric Case.
Toxic Shock Syndrome Caused by Streptococcus dysgalactiae Subspecies equisimilis: A Report of a Rare Pediatric Case.
Journal: Cureus
Published: February 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Imagawa's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile